Kojic acid

Kojic acid
Product Name Kojic acid
CAS No.: 501-30-4
Catalog No.: CFN94478
Molecular Formula: C6H6O4
Molecular Weight: 142.11 g/mol
Purity: >=98%
Type of Compound: Miscellaneous
Physical Desc.: Powder
Targets: Tyrosinase
Source: From the Aspergillus parasiticus.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $40/20mg
Kojic acid has been used as a food additive for preventing enzymatic browning of crustaceans and as a cosmetic agent for skin whitening. Kojic acid exhibits concentration-dependent scavenging activity on DPPH possessing strong antioxidant activity, it can reduce the mortality induced by gamma irradiation; it exhibits a competitive inhibition for the oxidation of chlorogenic acid and catechol by potato polyphenol oxidase (PPO) and of 4-methylcatechol and chlorogenic acid by apple PPO; it also has significant tyrosinase inhibitory activity.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Anal Bioanal Chem.2020, 412(12):3005-3015.
  • Jeju National University Graduate School2023, 24478
  • PLoS One.2017, 12(3):e0173585
  • Environ Toxicol.2024, 39(4):2417-2428.
  • Front Microbiol.2020, 11:583594.
  • APMIS.2019, 127(10):688-695
  • J Chromatogr B Analyt Technol Biomed Life Sci.2019, 1126-1127:121743
  • J Pharm Biomed Anal.2017, 140:274-280
  • Int J Mol Sci.2022, 23(15):8687.
  • Appl. Sci.2022, 12(17), 8646.
  • Capillarisin

    Catalog No: CFN90317
    CAS No: 56365-38-9
    Price: Inquiry(manager@chemfaces.com)
    Epimedonin B

    Catalog No: CFN92907
    CAS No: 1616061-69-8
    Price: Inquiry(manager@chemfaces.com)
    5,7-Dihydroxychromone

    Catalog No: CFN97761
    CAS No: 31721-94-5
    Price: $298/20mg
    5,7-Dihydroxychromone 7-rutinoside

    Catalog No: CFN92369
    CAS No: 52538-46-2
    Price: Inquiry(manager@chemfaces.com)
    3,5,7-Trihydroxychromone

    Catalog No: CFN89191
    CAS No: 31721-95-6
    Price: $368/5mg
    Eriosematin A

    Catalog No: CFN92552
    CAS No: 175448-02-9
    Price: Inquiry(manager@chemfaces.com)
    Eriosemation

    Catalog No: CFN92835
    CAS No: 162616-72-0
    Price: Inquiry(manager@chemfaces.com)
    Maltol

    Catalog No: CFN97949
    CAS No: 118-71-8
    Price: $30/20mg
    5-Hydroxymaltol 3-O-beta-D-glucoside

    Catalog No: CFN95641
    CAS No: N/A
    Price: $318/10mg
    Kojic acid

    Catalog No: CFN94478
    CAS No: 501-30-4
    Price: $40/20mg
    J Pharm Pharmacol. 1994 Dec;46(12):982-5.
    Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase.[Pubmed: 7714722]

    METHODS AND RESULTS:
    It was found that Kojic acid, which is used in cosmetics for its excellent whitening effect, inhibits catecholase activity of tyrosinase in a non-classical manner. A decrease in the initial velocity to a steady-state inhibited velocity can be observed over a few minutes. This time-dependence, which is unaltered by prior incubation of the enzyme with the inhibitor, is consistent with a first-order transition.
    CONCLUSIONS:
    The kinetic data obtained correspond to those for a postulated mechanism that involves the rapid formation of an enzyme inhibitor complex that subsequently undergoes a relatively slow reversible reaction. Kinetic parameters characterizing this type of inhibition were evaluated by means of nonlinear regression of product accumulation curves.
    Toxicol Sci. 2004 Sep;81(1):43-9.
    Enhancement of hepatocarcinogenesis by kojic acid in rat two-stage models after initiation with N-bis(2-hydroxypropyl)nitrosamine or N-diethylnitrosamine.[Pubmed: 15201437]
    Kojic acid (KA) has been used as a food additive for preventing enzymatic browning of crustaceans and as a cosmetic agent for skin whitening.
    METHODS AND RESULTS:
    In the present experiments, effects of KA on the induction of hepatic pre-neoplastic lesions in N-bis(2-hydroxypropyl)nitrosamine-initiated (experiment 1) and non-initiated (experiment 2) models, and its promoting influence in a medium-term liver bioassay (experiment 3) were investigated at dietary doses of up to 2% in male F344 rats. In experiment 1, 2% KA feeding induced significant increases in numbers (22.3 +/- 13.0 vs 8.5 +/- 3.4 in the 0%) and areas (0.37 +/- 0.29 vs 0.05 +/- 0.03 in the 0%) of glutathione-S-transferase P form (GST-P)-positive foci and toxic changes such as vacuolation of hepatocytes and microgranulomas. The development of GST-P-positive foci was pronounced in the animals with hepatocellular toxic changes. In experiment 2, numbers (0.65 +/- 0.57 vs 0.17 +/- 0.28 in the 0%) and areas (0.005 +/- 0.005 vs 0.0007 +/- 0.0012 in the 0%) of GST-P-positive foci and hepatocellular proliferating cell nuclear antigen (PCNA) expression (3.8 +/- 2.3 vs 2.6 +/- 0.7 in the 0%) were significantly increased by the 2% treatment. The PCNA-positive hepatocytes were abundantly localized around the vacuolated and granulomatous legions in both experiments 1 and 2. In experiment 3, significant increases in numbers (16.9 +/- 3.2 vs 8.4 +/- 2.7 in the 0%) and areas (1.62 +/- 0.39 vs 0.77 +/- 0.34 in the 0%) of GST-P-positive foci were again observed with 2% KA.
    CONCLUSIONS:
    These results demonstrate tumor-promoting and possible hepatocarcinogenic activity of KA at 2%, but the carcinogenic potential is likely to be weak. This study also indicated that enhanced replication of hepatocytes related to toxic changes might be involved as an underlying mechanism.
    Journal of Agricultural & Food Chemistry, 1991 , 39 (8) :1396-401.
    Inhibitory effect of kojic acid on some plant and crustacean polyphenol oxidases.[Reference: WebLink]
    Kojic acid exhibited a competitive inhibition for the oxidation of chlorogenic acid and catechol by potato polyphenol oxidase (PPO) and of 4-methylcatechol and chlorogenic acid by apple PPO.
    METHODS AND RESULTS:
    This compound showed a mixed-type inhibition for white shrimp, grass prawn, and lobster PPO when DL-beta-3,4-dihydroxyphenylalanine (DL-dopa) and catechol were used as substrates but a mixed-type and a competitive inhibition for mushroom PPO when DL-dopa and L-tyrosine were used, respectively. Potato and apple PPOs were shown to have much higher affinities for Dopa than for chlorogenic acid, 4-methylcatechol, and catechol.
    CONCLUSIONS:
    These two PPOs also had a higher affinity for Dopa than the other four PPOs. Kojic acid is thus an effective inhibitor of PPO on the oxidation of Dopa.
    Arch Pharm Res. 2003 Jul;26(7):532-4.
    Gamma-pyrone derivatives, kojic acid methyl ethers from a marine-derived fungus Alternaria [correction of Altenaria] sp.[Pubmed: 12934644]
    Kojic acid dimethyl ether (1), and the known Kojic acid monomethyl ether (2), Kojic acid (3) and phomaligol A (4) have been isolated from the organic extract of the broth of the marine-derived fungus Alternaria sp. collected from the surface of the marine green alga Ulva pertusa.
    METHODS AND RESULTS:
    The structures were assigned on the basis of comprehensive spectroscopic analyses. Each isolate was tested for its tyrosinase inhibitory activity. Kojic acid (3) was found to have significant tyrosinase inhibitory activity, but compounds 1, 2, and 4 were found to be inactive.
    Saudi Med J. 2009 Apr;30(4):490-3.
    Radioprotective effects of kojic acid against mortality induced by gamma irradiation in mice.[Pubmed: 19370273]
    To evaluate the protective effects of Kojic acid on mortality induced by gamma irradiation in mice. The efficacy was compared with amifostine as a reference radioprotector.
    METHODS AND RESULTS:
    This experimental study was conducted in the Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari and Babolsar Radiotherapy Hospital, Babolsar, Iran, between October 2006 and January 2008. Kojic acid was administrated subcutaneously as single doses of 142, 175, 232, and 350 mg/kg, one hour prior to a lethal dose of gamma irradiation (8 Gy). Amifostine was injected subcutaneously at a dose of 200 mg/kg at a similar irradiation dose. The mortality was recorded 30 days after irradiation. The antioxidant activity of the Kojic acid was assessed using the 1, 1-diphenyl-2-picrylhydrazyl free stable radical (DPPH) method. One hundred and twenty NMRI mice were divided into 6 groups with 20 mice in each group. At 30 days after treatment, the percentage of survival in each group was: control, 5%; 142 mg/kg, 5%; 175 mg/kg, 0%; 232 mg/kg, 30%; 350 mg/kg, 40%; and amifostine, 40% one hour treatment prior gamma irradiation. The survival rate was statistically increased in animals treated with Kojic acid (350 mg/kg), one hour prior irradiation, as compared with the irradiated control group.
    CONCLUSIONS:
    Kojic acid exhibited concentration-dependent scavenging activity on DPPH possessing strong antioxidant activity.
    Gymnoside III

    Catalog No: CFN95033
    CAS No: 899430-03-6
    Price: $238/10mg
    Glicoricone

    Catalog No: CFN95063
    CAS No: 161099-37-2
    Price: $318/5mg
    Isocarlinoside

    Catalog No: CFN95092
    CAS No: 83151-90-0
    Price: $318/5mg
    1,3,6-Trihydroxy-2-methylanthraquinone 3-O-alpha-L-rhamnosyl-(1->2)-beta-D-glucoside

    Catalog No: CFN95096
    CAS No: 87686-88-2
    Price: $318/10mg
    24-Hydroxymomordicine III

    Catalog No: CFN95169
    CAS No: N/A
    Price: $318/5mg
    Polygalin J

    Catalog No: CFN95175
    CAS No: N/A
    Price: $318/5mg
    Cichoriin

    Catalog No: CFN95196
    CAS No: 531-58-8
    Price: $100/20mg
    Epigambogellic acid

    Catalog No: CFN95438
    CAS No: 1352191-85-5
    Price: $318/5mg
    Oxytroflavoside A

    Catalog No: CFN95463
    CAS No: 1391144-80-1
    Price: $318/5mg
    Protocatechuic acid 4-O-beta-glucoside

    Catalog No: CFN95557
    CAS No: 7361-59-3
    Price: $413/5mg